N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide

C30H33N3O2 — CID 123332144

IUPACN-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide
SMILESCc1nc2ccc(-c3ccc4c(c3)CC(C)C(CC(=O)N(C)Cc3ccccc3)CCO4)cc2[nH]1
InChIInChI=1S/C30H33N3O2/c1-20-15-26-16-24(25-9-11-27-28(17-25)32-21(2)31-27)10-12-29(26)35-14-13-23(20)18-30(34)33(3)19-22-7-5-4-6-8-22/h4-12,16-17,20,23H,13-15,18-19H2,1-3H3,(H,31,32)
InChIKeyCRPCYEJCXCYFGL-UHFFFAOYSA-N
MW467.61 g/mol
LogP6.16
Rot. Bonds5

About N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide

N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide (PubChem CID 123332144) has the molecular formula C30H33N3O2 and a molecular weight of 467.61 g/mol. Its IUPAC name is N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide.

Molecular Properties

Compound NameN-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide
PubChem CID123332144
Molecular FormulaC30H33N3O2
Molecular Weight467.61 g/mol
Exact Mass467.26
IUPAC NameN-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide
SMILESCc1nc2ccc(-c3ccc4c(c3)CC(C)C(CC(=O)N(C)Cc3ccccc3)CCO4)cc2[nH]1
InChIInChI=1S/C30H33N3O2/c1-20-15-26-16-24(25-9-11-27-28(17-25)32-21(2)31-27)10-12-29(26)35-14-13-23(20)18-30(34)33(3)19-22-7-5-4-6-8-22/h4-12,16-17,20,23H,13-15,18-19H2,1-3H3,(H,31,32)
InChIKeyCRPCYEJCXCYFGL-UHFFFAOYSA-N
XLogP6.16
TPSA58.22 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500467.61
LogP ≤ 56.16
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide?
The IUPAC name of N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide (CID 123332144) is N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide.
What is the SMILES notation for N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide?
The canonical SMILES for N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide is Cc1nc2ccc(-c3ccc4c(c3)CC(C)C(CC(=O)N(C)Cc3ccccc3)CCO4)cc2[nH]1.
What is the InChIKey of N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide?
The InChIKey is CRPCYEJCXCYFGL-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H33N3O2/c1-20-15-26-16-24(25-9-11-27-28(17-25)32-21(2)31-27)10-12-29(26)35-14-13-23(20)18-30(34)33(3)19-22-7-5-4-6-8-22/h4-12,16-17,20,23H,13-15,18-19H2,1-3H3,(H,31,32).
What are the key properties of N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide?
N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide has a molecular weight of 467.61 g/mol, XLogP of 6.16, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-benzyl-N-methyl-2-[5-methyl-8-(2-methyl-3H-benzimidazol-5-yl)-3,4,5,6-tetrahydro-2H-1-benzoxocin-4-yl]acetamide is sourced from PubChem (CID 123332144), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).